Stockreport

Lexicon (LXRX) Dips on Post Hoc Analysis Data on Sotagliflozin [Yahoo! Finance]

Lexicon Pharmaceuticals, Inc.  (LXRX) 
Last lexicon pharmaceuticals, inc. earnings: 4/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: lexpharma.com/investors
PDF Data from the new post hoc analysis showed that treatment with sotagliflozin improved glycemic control in the given patient population, while also successfully lowering [Read more]